84 results match your criteria: "centre d'addictovigilance[Affiliation]"

From regional signal to alert in addictovigilance.

Therapie

October 2024

Inserm U 1058, Pathogenesis and Control of Chronic Infections (PCCI), centre d'addictovigilance, Montpellier University Hospital, 34000 Montpellier, France.

France has several monitoring systems that form the foundation of its health safety surveillance. This system is designed for the early detection of signals and their swift into an action system that enables timely, appropriate, and effective interventions to protect public health. These signals are considered alerts when sufficiently validated after an initial risk assessment and if they represent a potential threat to public health, necessitating an appropriate response.

View Article and Find Full Text PDF

Isotonitazene, a synthetic opioid from an emerging family: The nitazenes.

Therapie

November 2024

Service de pharmacologie médicale et toxicologie, centre d'addictovigilance, CHU de Montpellier, 34295 Montpellier, France; Pathogenesis and Control of Chronic Infections (PCCI), Inserm U 1058, 34000 Montpellier, France. Electronic address:

From 2019, in the United States and Europe, the synthetic opioid market has diversified with the appearance of the 2-benzylbenzimidazole family, commonly named "nitazenes". In vitro studies show that these synthetic opioids have much higher affinities on μ-opioid receptors: 100 times more than morphine, and slightly higher than fentanyl for isotonitazene, increasing the risk of overdose. In south of France, isotonitazene (IZN) was identified for the first time in March 2023.

View Article and Find Full Text PDF

Aim: Patients with chronic non-cancer pain are referred to pain centres to improve their pain treatment. The discontinuation of pain medications in case of poor efficacy can be difficult to accept for patients, particularly opioid analgesics. Previous research has described that from the patients' perspective, the psychological relief of a negative effect of chronic pain and withdrawal symptoms of prescription opioids represent drivers of persistent use and first stage of opioid use disorder, despite insufficient pain relief.

View Article and Find Full Text PDF

Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey.

BMC Public Health

April 2024

Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes Université, CHU Nantes, F-44000, Nantes, France.

Background: Chronic use of cannabis is associated with an increased risk of psychosocial, mental and physical health impairments. Sociohealth institutions reach a very limited proportion of cannabis users in need of treatment. Using data collected from festival attendees, this study aimed to estimate the prevalence of dependent cannabis users and to characterize cannabis dependence.

View Article and Find Full Text PDF

Introduction: Ammonia solution (ammonium hydroxide) is used to convert cocaine hydrochloride to freebase cocaine. Due to its causticity, unintentional exposure to ammonia in a substance use context can result in injury. The objective of this study was to describe the characteristics of unintentional oral and buccal ammonia solution exposure in a substance use context.

View Article and Find Full Text PDF

Background: The combination dextropropoxyphene/paracetamol (DXP/P) was the most prescribed opioid analgesic until its withdrawal in 2011.

Objectives: This study investigated dispensations of analgesics in chronic users of DXP/P during the 18 months following its withdrawal.

Methods: A cross-sectional study repeated yearly was conducted by using the French reimbursement database from 2006 to 2015.

View Article and Find Full Text PDF

Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown.

Public Health

October 2023

Service de Pharmacologie Médicale, CHU de Bordeauxx, Centre de Pharmacovigilance de Bordeaux, F-33000 Bordeaux, France; University Bordeaux, INSERM, BPH, U1219, CHU de Bordeaux, F-33000 Bordeaux, France; Service de Pharmacologie Médicale, Centre d'Addictovigilance, CHU de Bordeaux, F-33000 Bordeaux, France. Electronic address:

Objectives: At the beginning of the COVID-19 pandemic, the French Addictovigilance Network drew attention to the need to facilitate access to methadone while ensuring its safe use, in order to avoid the occurrence of overdoses and deaths. The objectives of the study were to assess the impact of the lockdowns on the incidence of methadone-use-related hospitalisations (MUHs) and describe the characteristics of patients and hospitalisations.

Study Design: An interrupted time series using the unobserved components model was performed to predict the monthly incidence of MUHs in 2020 on the basis of previous years' data and compared with MUHs observed.

View Article and Find Full Text PDF

[Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020].

Therapie

June 2024

Centre d'addictovigilance, service de pharmacologie clinique, hôpital de la Timone, Assistance publique-Hôpitaux de Marseille, Aix-Marseille université, institut de neurosciences des systèmes, Inserm UMR1106, 13005 Marseille, France.

Introduction: Due to the risk of overdoses increase especially with methadone, a reinforced monitoring has been set up by the French Addictovigilance Network following the first lockdown related to coronavirus disease 2019 (COVID-19). In this context, we managed a specific study to analyze overdoses related to methadone in 2020 compared to 2019.

Material And Methods: We analyzed methadone-related overdoses which occurred in 2019 and 2020 from two sources: DRAMES program (deaths with toxicological analysis) and the French pharmacovigilance database (BNPV) (overdoses that did not lead to death).

View Article and Find Full Text PDF

Backgrounds: The Covid-19 pandemic offered a unique opportunity to investigate trends in hospitalizations related to psychoactive substance intoxication, since the usual health burden of social use at parties and gatherings was likely to be decreased during lockdowns and curfew periods. Since young adults are the main users of psychoactive substances for experimental and recreational purposes, this study identified and compared hospitalization trends in young adults and adults over 30 years old.

Methods: This national cohort study was conducted using the French hospital discharge database.

View Article and Find Full Text PDF

Introduction: Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the use of psychoactive substances coordinated by the French National Agency for the Safety of Medicines and Health Products.We present the French national survey of nitrous oxide.

View Article and Find Full Text PDF
Article Synopsis
  • Recreational use of nitrous oxide (NO) can lead to serious neurological and psychological disorders, prompting the need for reliable biological markers to diagnose abuse.
  • The study analyzed data from 52 chronic NO abusers to evaluate the effectiveness of total vitamin B12, homocysteine, and methylmalonic acid (MMA) in correlating with NO consumption and clinical outcomes.
  • While no specific marker was found for the level of NO consumption, elevated homocysteine levels indicated recent use, and MMA showed a stronger correlation with the severity of clinical symptoms.
View Article and Find Full Text PDF

Plasma Methionine and Clinical Severity in Nitrous Oxide Consumption.

Toxics

December 2022

CHU de Lille, Service Hormonologie Métabolisme Nutrition Oncologie, F-59000 Lille, France.

In the last few years, there has been an increase in the recreational use of nitrous oxide (N2O), which can lead to neurological symptoms such as sensory or motor disorders. The literature links these symptoms to a functional inactivation of vitamin B12 by oxidation of its cobalt ion, which prevents the vitamin B12 from acting as a cofactor for methionine synthase. Thus, demyelination related to methionine deficiency could be responsible for the neurological disorders associated with N2O consumption, including the combined sclerosis of the spinal cord.

View Article and Find Full Text PDF

Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care.

Int J Environ Res Public Health

November 2022

CHU Clermont-Ferrand, Service de Pharmacologie Médicale, Centre d'Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Analgesic opioid (AO) misuse by patients ranges from 0% to 50%. General practitioners are the first prescribers of AO. Our objective was to validate the Prescription Opioid Misuse Index (POMI) in primary care.

View Article and Find Full Text PDF

[Nitrous oxide poisoning: Increasing consumption with serious consequences].

Ann Pharm Fr

May 2023

CHU de Lille, service hormonologie métabolisme nutrition oncologie, 59000 Lille, France. Electronic address:

View Article and Find Full Text PDF

Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey.

Therapie

March 2023

Service de pharmacologie médicale et clinique, centre d'addictovigilance (CEIP-A), CHU de Toulouse - UFR santé, université de Toulouse, 31000 Toulouse, France.

Context: Substance use disorders during pregnancy are associated with antenatal, neonatal and long-term adverse drug reactions in children. The aim of this study was to describe, using data from OPPIDUM survey, the evolution of illicit substance use or diverted prescription drug use among pregnant women visiting French addiction care centres from 2005 to 2018.

Material And Method: The current study focused on women of childbearing age (15-44years old) identified as pregnant, and included in the OPPIDUM survey from 2005 to 2018.

View Article and Find Full Text PDF

Addictovigilance in women, the hidden part of the iceberg?

Therapie

March 2023

Service de pharmacologie médicale et clinique, centre d'addictovigilance (CEIP-A), CHU de Toulouse-UFR santé, université de Toulouse, 31000 Toulouse, France. Electronic address:

Epidemiology of substance use disorders and their complications is driven by a male predominance, and women, even if they are more and more prevalent, are never specifically represented in studies in the field. Apart from the time of pregnancy, which in itself requires specific prevention, treatment and follow-up, the importance of the sex of women in the complications of substance abuse is neglected. To illustrate, we described some characteristics of women identified in the addictovigilance information system in France and Europe, related to drug use disorders (both for illicit substances and medications).

View Article and Find Full Text PDF

Minors and young adult's hospitalizations after "chimique" consumption in Mayotte Island: Which substances are involved?

Therapie

May 2023

Université Bordeaux, Inserm, BPH, U1219, 33000 Bordeaux, France; CHU de Bordeaux, centre d'addictovigilance de Bordeaux et Départements d'Outre-Mer, service de pharmacologie médicale, 33000 Bordeaux, France. Electronic address:

Objectives: Over the last 10 years, the use of an unknown drug called "chimique" has emerged, among adolescents and young adults in precarious situations in Mayotte Island. To date, the exact composition of "chimique" is still poorly documented, but seizures made on the Island at the same time indicated that it would be mainly composed of synthetic cannabinoids receptor agonists (SCRAs). The objective of this study was to identify which substances, among those consumed under the name of "chimique", leading to hospital admissions.

View Article and Find Full Text PDF

[Hospitalizations after substance use during the COVID-19 pandemic].

Therapie

May 2023

Service de pharmacologie médicale, CHU de Bordeaux, centre de pharmacovigilance de Bordeaux, 33000 Bordeaux, France; Université de Bordeaux, Inserm, BPH, U1219, 33000 Bordeaux, France.

View Article and Find Full Text PDF

Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France.

Rev Med Interne

July 2022

Centre antipoison de Paris - Fédération de toxicologie (FeTox), hôpital Fernand-Widal, AP-HP, 75010 Paris, France; Inserm, UMRS-1144, Faculté de pharmacie, 75006 Paris, France; UFR de médecine, université de Paris, 75010 Paris, France. Electronic address:

Introduction: Recreational use of nitrous oxide (NO) is increasing in Western countries, including France. During the COVID-19 pandemic, some authors warned that recreational NO use could increase further as the supply of illicit drugs was impacted by various containment measures.

Methods: We retrospectively analyzed NO exposures reported to the Paris Poison Control Center (France) from 2010/01/01 to 2021/04/15.

View Article and Find Full Text PDF

Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F).

Can J Anaesth

August 2022

Service de Pharmacologie médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Service Psychiatrie-Addictologie, Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand, France.

Purpose: The Prescription Opioid Misuse Index scale (POMI) is a brief questionnaire used to assess opioid prescription misuse. In view of the increase in the prescription of opioid analgesics for chronic noncancer pain (CNCP), this tool is particularly useful during medical consultations to screen opioid misuse in patients using opioids. We sought to generate and validate a French-European translation of the POMI.

View Article and Find Full Text PDF

Nitrous oxide abuse in the emergency practice, and Review of toxicity mechanisms and potential markers.

Food Chem Toxicol

April 2022

Inserm, Univ. Lille EA 7364 RADEME, CHU Lille, Centre de Biologie Pathologie Génétique, UF Métabolisme Général et Maladies Rares, F-59000, Lille, France. Electronic address:

Nitrous oxide (NO) toxicity is a concern common to several medical fields. Here, retrospective study of four NO abuses with neurological signs in the emergency practice provides a preliminary basis for a metabolic Discussion/Review. This latter highlights NO abuse as pathology of DNA/RNA/protein methylations, for instance consistent with impairments of protein arginine methyltransferases involved in myelinogenesis and myelopathy in patients.

View Article and Find Full Text PDF

Little is known about psychoactive substance use in students, apart from tobacco, alcohol, and cannabis. This study investigated the prevalence of substance use and overlap between various psychoactive substances in students. This cross-sectional study was conducted in 10 066 students included in the i-Share cohort between January 1, 2015, and December 31, 2017.

View Article and Find Full Text PDF

[Methylmalonic acid: Specific marker of chronic nitrous oxide abuse?].

Rev Med Interne

March 2022

Service d'hormonologie, métabolisme, nutrition, oncologie, CHU de Lille, 59000 Lille, France.

View Article and Find Full Text PDF

Management of Pregabalin Use Disorder: A Case Series.

J Psychoactive Drugs

October 2022

Département de Pharmacologie Médicale Et Toxicologie, Centre d'Addictovigilance, Chu Montpellier, Univ Montpellier, Montpellier, France.

Pregabalin is indicated for the treatment of partial epilepsy, generalized anxiety disorder, and neuropathic pain. The first reports on pregabalin use disorder have been published in Europe in 2010 and notified to the French Addictovigilance Network (FAN) in 2011. The management of pregabalin use disorder is challenging due to the risks associated with the abrupt withdrawal and lack of guidelines.

View Article and Find Full Text PDF